Like Growing Dividend Income? Buy This Dividend King
Companies that possess the characteristic of consistency are arguably the foundation upon which all income portfolios should be built. That is because businesses that reliably grow over time can support an increasing dividend payout.
No healthcare company embodies consistency more than Johnson Johnson (NYSE: JNJ): The business has grown its dividend for 61 consecutive years, the lengthiest dividend growth streak in the entire healthcare sector. Let's dig into what makes J such a great pick for income investors.
Aside from perhaps the health insurance giant UnitedHealth Group, there is arguably no company that is as dominant in the healthcare sector as J That is because in 2022, the company had 29 platforms/products that each topped $1 billion in annual sales: 14 in its pharmaceutical segment, 11 in its medtech segment, and four in its consumer health segment. This robust portfolio of medicines, medical devices, and consumer health products supports J's $435 billion market capitalization, which makes it the biggest pharmaceutical company in the world.
Source Fool.com
UnitedHealth Group Inc. Aktie
Die Community sieht UnitedHealth Group Inc. positiv: Viel mehr Buy- als Sell-Einschätzungen.
Für UnitedHealth Group Inc. ergibt sich ein leicht positives Potenzial, angesichts eines Kursziels von 543 € im Vergleich zu 468.45 €.
